Amikacin resistance developing in patients with Pseudomonas aeruginosa bronchopneumonia.
D000583:Amikacin / Q000627:therapeutic use*; D001996:Bronchopneumonia / Q000188:drug therapy*; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects*
D007612:Kanamycin; D000583:Amikacin